‘Pharma Bro’ tearfully apologizes, then sentenced to prison
Martin Shrkeli, the smirking "Pharma Bro" vilified for jacking up the price of a lifesaving drug, was sentenced Friday to seven years in prison for defrauding investors.
Martin Shkreli is interviewed by Maria Bartiromo during her "Mornings with Maria Bartiromo" program on the Fox Business Network, in New York, Tuesday, Aug. 15, 2017. (Richard Drew/AP Photo)
The self-promoting “Pharma Bro” vilified for jacking up the price of a lifesaving drug has been sentenced to prison for securities fraud.
Pharmaceutical executive Martin Shkreli was sentenced Friday to seven years in prison by U.S. District Judge Kiyo Matsumoto after he was convicted last year of lying to investors in two failed hedge funds.
Shkreli cried as he told the judge that he made many mistakes and he apologized to investors.
His attorney argued that he deserved 18 months or less and shouldn’t be punished for being outspoken. The judge says she did not take his outside actions into account.
Shkreli had been free on bail until a judge jailed him for offering a $5,000 bounty to anyone who could get a lock of Hillary Clinton’s hair last year.
He remains in custody.
WHYY is your source for fact-based, in-depth journalism and information. As a nonprofit organization, we rely on financial support from readers like you. Please give today.
The Supreme Court wrestles with OxyContin maker’s bankruptcy deal, with billions of dollars at stake
The justices on Monday seemed by turns reluctant to break up an exhaustively negotiated agreement, but also leery of somehow rewarding the Sacklers.
11 months ago
Judge rules against opioid-maker Johnson & Johnson, orders $572M payment
An Oklahoma judge found Johnson & Johnson and its subsidiaries helped fuel the opioid crisis and ordered the consumer products giant to pay $572M to clean up the problem.
5 years ago
Feds: Ex-CEO is first drug exec indicted in opioid crisis
The indictment alleges former Rochester Drug Co-Operative CEO Laurence Doud III ordered subordinates to ignore red flags about pharmacy customers to maximize company revenue.
6 years ago